CD82 and ovarian carcinoma: In addition, they documented that treating ovarian cells with KAI1-enriched exosomes efficiently prevented in vitro adhesion and migration of ovarian cancer cells, and this may signify a new strategy for treating ovarian cancer metastasis (J. Li et al., 2020).